6.
Fischer S, Cleare A
. Cortisol as a predictor of psychological therapy response in anxiety disorders-Systematic review and meta-analysis. J Anxiety Disord. 2017; 47:60-68.
DOI: 10.1016/j.janxdis.2017.02.007.
View
7.
Knowles K, Tolin D
. Mechanisms of Action in Exposure Therapy. Curr Psychiatry Rep. 2022; 24(12):861-869.
DOI: 10.1007/s11920-022-01391-8.
View
8.
Bigos K, Folan M, Jones M, Haas G, Kroboth F, Kroboth P
. Dysregulation of neurosteroids in obsessive compulsive disorder. J Psychiatr Res. 2008; 43(4):442-5.
PMC: 2654381.
DOI: 10.1016/j.jpsychires.2008.04.007.
View
9.
Kellner M, Nowack S, Wortmann V, Yassouridis A, Wiedemann K
. Does Pregnenolone Enhance Exposure Therapy in Obsessive-Compulsive Disorder? - A Pilot, Interim Report of a Randomized, Placebo-Controlled, Double-Blind Study. Pharmacopsychiatry. 2016; 49(2):79-81.
DOI: 10.1055/s-0035-1569371.
View
10.
Sripada R, Rauch S
. Between-session and within-session habituation in Prolonged Exposure Therapy for posttraumatic stress disorder: a hierarchical linear modeling approach. J Anxiety Disord. 2015; 30:81-7.
DOI: 10.1016/j.janxdis.2015.01.002.
View
11.
Soravia L, Heinrichs M, Aerni A, Maroni C, Schelling G, Ehlert U
. Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci U S A. 2006; 103(14):5585-90.
PMC: 1414637.
DOI: 10.1073/pnas.0509184103.
View
12.
Baker A, Mystkowski J, Culver N, Yi R, Mortazavi A, Craske M
. Does habituation matter? Emotional processing theory and exposure therapy for acrophobia. Behav Res Ther. 2010; 48(11):1139-43.
PMC: 2956764.
DOI: 10.1016/j.brat.2010.07.009.
View
13.
Hu Y, Cardounel A, Gursoy E, Anderson P, Kalimi M
. Anti-stress effects of dehydroepiandrosterone: protection of rats against repeated immobilization stress-induced weight loss, glucocorticoid receptor production, and lipid peroxidation. Biochem Pharmacol. 2000; 59(7):753-62.
DOI: 10.1016/s0006-2952(99)00385-8.
View
14.
Merz C, Wolf O
. How stress hormones shape memories of fear and anxiety in humans. Neurosci Biobehav Rev. 2022; 142:104901.
DOI: 10.1016/j.neubiorev.2022.104901.
View
15.
Benito K, Machan J, Freeman J, Garcia A, Walther M, Frank H
. Measuring fear change within exposures: Functionally-defined habituation predicts outcome in three randomized controlled trials for pediatric OCD. J Consult Clin Psychol. 2018; 86(7):615-630.
PMC: 6023553.
DOI: 10.1037/ccp0000315.
View
16.
Fischer S, Zilcha-Mano S
. Why Does Psychotherapy Work and for Whom? Hormonal Answers. Biomedicines. 2022; 10(6).
PMC: 9220228.
DOI: 10.3390/biomedicines10061361.
View
17.
Kellner M, Yassouridis A, Adel F, Muhtz C, Jelinek L, Wiedemann K
. Cortisol, DHEA and DHEA-S during exposure therapy in patients with obsessive-compulsive disorder - secretion patterns and prediction of treatment response. Psychiatry Res. 2020; 291:113288.
DOI: 10.1016/j.psychres.2020.113288.
View
18.
Norton P, Hayes-Skelton S, Klenck S
. What happens in session does not stay in session: changes within exposures predict subsequent improvement and dropout. J Anxiety Disord. 2011; 25(5):654-60.
PMC: 3089678.
DOI: 10.1016/j.janxdis.2011.02.006.
View